Residency · Residency · Pediatrics
Pediatric Bone and Joint Infections
Overview
Septic arthritis and osteomyelitis are common pediatric infections requiring prompt diagnosis and treatment. Most occur via hematogenous seeding, with peak incidence in children under 5 years. Delay in treatment can lead to permanent joint damage, growth plate injury, and chronic osteomyelitis. S. aureus (including MRSA) is the most common pathogen across all ages. The key clinical decisions center on distinguishing septic arthritis from transient synovitis, choosing empiric antibiotics, and determining the duration and route of therapy.
Septic Arthritis
Epidemiology
Septic arthritis is most common in children under 3 years and predominantly affects large joints: the knee (40%), hip (20%), ankle (15%), and elbow (10%). Hip septic arthritis is an orthopedic emergency because delay can lead to avascular necrosis of the femoral head.
Pathogenesis
Hematogenous seeding is the most common mechanism, followed by direct inoculation (trauma, surgery) and contiguous spread from adjacent osteomyelitis, which is especially relevant in neonates where metaphyseal vessels cross the physis.
Microbiology
S. aureus (both MSSA and MRSA) is the most common pathogen at all ages. Kingella kingae is increasingly recognized as the leading cause in children 6 months to 4 years; it is a fastidious organism that may be missed on standard culture, so synovial fluid should be inoculated into a blood culture bottle. Group B Streptococcus is the predominant pathogen in neonates. Group A Streptococcus can cause infection at any age. N. gonorrhoeae should be considered in sexually active adolescents, presenting with polyarticular involvement, tenosynovitis, and the dermatitis-arthritis syndrome. Salmonella is the classic pathogen in sickle cell disease.
Clinical Presentation
Children present with acute onset joint pain, swelling, warmth, and erythema. Fever may be present but can be absent, especially with K. kingae infections. Refusal to bear weight or use the affected limb (pseudoparalysis in infants) is characteristic. In hip septic arthritis, the infant holds the hip in flexion, abduction, and external rotation and resists any passive range of motion. Limited and painful range of motion is the hallmark finding.
Kocher Criteria (Hip -- Septic Arthritis vs. Transient Synovitis)
The Kocher criteria were developed to differentiate septic arthritis from transient synovitis of the hip. The four criteria are fever of 38.5C or higher, non-weight-bearing status, ESR of 40 mm/hr or higher, and WBC of 12,000/mm3 or higher. The modified Kocher criteria (Caird criteria) add CRP greater than 20 mg/L as a fifth predictor. The predicted probability of septic arthritis rises with the number of criteria met: 0 criteria yields less than 0.2% probability, 1 criterion yields 3%, 2 criteria yield 40%, 3 criteria yield 93%, and 4 criteria yield 99%. A key limitation is that the criteria do not account for K. kingae, which often presents without fever and with a normal WBC, and the criteria perform less well in practice than in the original validation.
Diagnosis
Arthrocentesis is mandatory if septic arthritis is suspected, serving as both diagnostic and therapeutic. Joint fluid with WBC greater than 50,000/mm3 (typically 75-100% PMNs) strongly suggests septic arthritis. Gram stain is positive in approximately 50% of bacterial arthritis cases. Culture of synovial fluid and blood should be obtained, with synovial fluid inoculated into a blood culture bottle for K. kingae detection. Blood tests reveal leukocytosis on CBC, elevated CRP and ESR, and positive blood cultures in approximately 40% of cases. Ultrasound detects joint effusion (especially useful for the hip) but cannot distinguish septic from non-septic effusion. X-ray may show joint widening and soft tissue swelling and rules out fracture. MRI is used when diagnostic uncertainty exists to identify adjacent osteomyelitis or abscess.
<image>Diagnostic approach to the limping child with suspected septic arthritis showing Kocher criteria assessment (fever, non-weight-bearing, elevated ESR, elevated WBC), joint ultrasound for effusion, arthrocentesis with synovial fluid analysis (WBC count, Gram stain, culture in blood culture bottle for Kingella), and MRI for complex cases with adjacent bone involvement</image>
Transient Synovitis
Transient synovitis is the most common cause of acute hip pain in children aged 3-8 years. It is a benign, self-limited inflammatory condition that often follows a viral upper respiratory infection. Children have low-grade or no fever, mild limitation of range of motion, and may still bear weight. Laboratory values are normal or only mildly elevated. Treatment is NSAIDs and rest, with resolution in 1-2 weeks. The critical point is that if septic arthritis cannot be confidently excluded clinically, arthrocentesis must be performed.
Osteomyelitis
Epidemiology
Osteomyelitis is most common in children under 5 years with a slight male predominance. It most frequently affects the long bones (femur, tibia, humerus) at the metaphysis, which is the most common site due to sluggish blood flow in metaphyseal venous sinusoids that allows bacterial seeding.
Microbiology
S. aureus (MSSA and MRSA) is the most common pathogen at all ages. K. kingae is the leading cause in children 6 months to 4 years. Group B Streptococcus predominates in neonates. Salmonella is associated with sickle cell disease (though S. aureus remains more common overall even in SCD). Pseudomonas should be considered with puncture wounds through shoes causing plantar osteomyelitis. Bartonella can cause cat scratch disease-associated osteomyelitis.
Clinical Presentation
Children present with focal bone pain, tenderness, and warmth, along with a limp or refusal to bear weight. Fever is variable and may be absent early or with K. kingae infections. Swelling and erythema over the affected bone with point tenderness on palpation are typical. Neonates may present with pseudoparalysis without systemic signs.
Diagnosis
CRP is the most useful blood test for monitoring response to treatment. ESR, CBC, and blood culture (positive in 40-60%) should also be obtained. On X-ray, findings are normal in the first 10-14 days, with periosteal reaction and lytic changes appearing later. MRI with gadolinium is the gold standard imaging modality with sensitivity and specificity exceeding 90%, identifying bone marrow edema, subperiosteal abscess, and adjacent soft tissue involvement. Bone scan (Tc-99m) is useful when multifocal disease is suspected or MRI is unavailable but is less specific. Ultrasound can detect subperiosteal fluid collections but cannot assess bone marrow. Bone aspiration or biopsy should be considered for culture when blood cultures are negative and is essential for guiding antibiotic therapy, especially in MRSA-prevalent areas.
Complications of S. aureus Osteomyelitis
Subperiosteal abscess requires surgical drainage. Panton-Valentine leukocidin (PVL)-positive MRSA is associated with deep vein thrombosis, septic pulmonary emboli, multifocal disease, and myositis. Chronic osteomyelitis leads to sequestrum formation and sinus tracts. Growth plate injury can result in limb length discrepancy or angular deformity.
Treatment
Empiric Antibiotic Selection
| Patient Group | Empiric Antibiotic | Rationale |
|---|---|---|
| Standard (MRSA <10%) | Nafcillin or cefazolin | Covers MSSA and K. kingae |
| MRSA >10%, non-severe | Clindamycin | If local clindamycin susceptibility >90% |
| Severe/critically ill | Vancomycin | Broad MRSA coverage pending cultures |
| Neonate | Nafcillin (or vancomycin) + gentamicin | Covers GBS, S. aureus, gram-negatives |
| Sickle cell disease | Ceftriaxone + vancomycin (or nafcillin) | Covers Salmonella + S. aureus |
| Puncture wound (foot) | Add anti-pseudomonal agent | Pseudomonas risk |
Empiric therapy must cover S. aureus (including MRSA) and K. kingae (in young children). When MRSA prevalence is below 10%, nafcillin or cefazolin is appropriate. When MRSA prevalence exceeds 10% or disease is severe, clindamycin is used if local MRSA clindamycin susceptibility exceeds 90%, or vancomycin if the patient is critically ill or clindamycin resistance exceeds 10%. Neonates should receive nafcillin or vancomycin plus gentamicin or cefotaxime to cover GBS and gram-negatives. For sickle cell disease, coverage for both S. aureus and Salmonella is needed (ceftriaxone plus vancomycin or nafcillin). Therapy should be adjusted based on culture and sensitivity results.
IV-to-Oral Transition
The traditional approach involved prolonged IV antibiotics (4-6 weeks for osteomyelitis, 3-4 weeks for septic arthritis). The modern approach uses early IV-to-oral transition guided by clinical improvement and CRP decline. The switch to oral antibiotics is appropriate when the patient has been afebrile for 24-48 hours, is clinically improving, CRP is declining (not rising), the organism is identified with an oral option available, and the family is reliable. Oral options include cephalexin, clindamycin, TMP-SMX (for MRSA), and amoxicillin-clavulanate, with high-dose oral therapy (2-3 times standard dosing) used for osteomyelitis. Total duration for osteomyelitis is traditionally 4-6 weeks, though recent evidence supports 3-4 weeks total with early oral switch for uncomplicated cases. Septic arthritis requires 2-4 weeks total. K. kingae infections may respond to shorter courses of 2-3 weeks.
Surgical Management
For septic arthritis, surgical drainage or washout is required for the hip (emergency), shoulder, and any joint not responding to antibiotics plus aspiration. Hip cases require open arthrotomy or arthroscopic washout. Other joints may be managed with repeated needle aspiration if responding clinically. For osteomyelitis, surgical drainage is indicated for subperiosteal or intraosseous abscess, with debridement of necrotic bone. General indications for surgery include abscess formation, failure to improve after 48-72 hours of appropriate antibiotics, and extensive disease.
<image>Treatment algorithm for pediatric osteomyelitis and septic arthritis showing empiric antibiotic selection based on MRSA prevalence and patient age, IV-to-oral transition criteria (afebrile, improving, CRP declining, organism identified), total treatment duration for each condition, and surgical indications (hip septic arthritis, abscess formation, treatment failure)</image>
Monitoring Response to Treatment
CRP is the most useful marker and should decline by 50% within 48-72 hours; failure to decline suggests a complication, abscess, or wrong antibiotic. ESR is slow to normalize (taking weeks) and is less useful for acute monitoring. Clinical assessment of pain improvement, weight-bearing, and fever resolution is essential. Repeat imaging with MRI is indicated if the patient is not improving or if there is concern for abscess but is not needed routinely if the patient is responding well.
Clinical Pearls
Synovial fluid and bone aspirates should always be inoculated into blood culture bottles because K. kingae is difficult to culture on standard media but grows well in blood culture systems. A negative Kocher criteria score does not exclude septic arthritis caused by K. kingae, as these children are often afebrile with a normal WBC. Hip septic arthritis is an orthopedic emergency, and delay in drainage can lead to avascular necrosis of the femoral head. PVL-positive MRSA osteomyelitis can cause DVT and septic pulmonary emboli, so respiratory symptoms in a child with osteomyelitis should raise this concern. CRP is the best marker for monitoring treatment response, and a rising CRP after 48 hours of antibiotics should prompt re-evaluation and imaging. A puncture wound through a shoe combined with foot osteomyelitis should prompt consideration of Pseudomonas, with antipseudomonal coverage added accordingly.
Key Controversy: Short-Course IV-to-Oral Antibiotic Transition
The traditional 4-6 weeks of IV antibiotics for osteomyelitis is being challenged by evidence supporting early oral switch. Finnish studies demonstrated that 3-4 weeks total (including early oral switch at 2-4 days) produced outcomes equivalent to prolonged IV therapy for uncomplicated osteomyelitis. The adult POET trial showed IV-to-oral switch for bone and joint infections was non-inferior. Pediatric adaptations use high-dose oral antibiotics with CRP-guided monitoring. Concerns include adherence to oral medications in children, palatability, absorption variability, and the possibility that MRSA infections may require longer IV therapy. This approach is not appropriate for complicated infections (abscess, PVL-positive MRSA, extensive disease), neonates, or immunocompromised patients. The overall trend is growing acceptance of early oral transition in uncomplicated pediatric osteoarticular infections with close follow-up.
References
- Peltola H, et al. Short- versus Long-Term Antimicrobial Treatment for Acute Hematogenous Osteomyelitis in Children. Pediatr Infect Dis J. 2010;29(12):1123-1128.
- Kocher MS, et al. Differentiating Between Septic Arthritis and Transient Synovitis of the Hip in Children. J Bone Joint Surg Am. 1999;81(12):1662-1670.
- Dartnell J, et al. Haematogenous Acute and Subacute Pediatric Osteomyelitis. J Bone Joint Surg Br. 2012;94(5):584-595.
- Li HK, et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection (POET Trial). N Engl J Med. 2019;380(5):425-436.
- Yagupsky P, et al. Kingella kingae: An Emerging Cause of Invasive Infections in Young Children. Clin Infect Dis. 2011;17(11):1966-1972.
- McNeil JC, et al. Osteoarticular Infections in Children Due to Staphylococcus aureus. Pediatr Clin North Am. 2021;68(1):79-96.
